Stewart Appelrouth
Director · AIM ImmunoTech Inc.
- 2024
- Dec 17, 2024
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Stewart Appelrouth files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Thomas K. Equels - $24K in AIM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Stewart Appelrouth?
Stewart Appelrouth is a corporate insider, tracked as Director of AIM ImmunoTech Inc. (AIM). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Stewart Appelrouth last file a Form 4?
The most recent primary Form 4 on record is dated 17 December 2024, one of 4 filings going back to 2024.
Has Stewart Appelrouth been buying or selling stock?
Recorded transactions: 3 open-market purchases ($18K) and 0 open-market sales across all tracked filings.
